Download Pharm D 4th Year 2019 May 383819 Pharmacotherapeutics Iii Question Paper

Download Pharm-D (Doctor of Pharmacy) 4th Year (Fourth Year) 2019 May 383819 Pharmacotherapeutics Iii Previous Question Paper

[LO 819] MAY 2019 Sub. Code: 3819

PHARM. ?D? AND PHARM. ?D? (POST BACCALAUREATE)
DEGREE EXAMINATION
(2009-2010 Regulation)
FOURTH YEAR
PAPER I - PHARMACOTHERAPEUTICS ? III

Q.P. Code: 383819
Time : Three hours Maximum : 70 Marks

I. Elaborate on: (4 x 10 = 40)

1. Define Viral Hepatitis. List and compare the development and management of
different types of viral hepatitis.
2. a) Define Schizophrenia and discuss about classification and its sign and
symptoms.
b) Write the management of Schizophrenia.
3. Explain Alzheimer?s disease and its development. Add notes on the management
of Alzheirmer?s disease.
4. a) Define Anemia. Discuss briefly the types, etiology, pathophysiology and
clinical manifestation of different types of anemia.
b) Discuss the pharmacotherapy for different types of anemia.

II. Write notes on: (6 x 5 = 30)

1. Pharmacist?s common therapeutic problems in the treatment of inflammatory
bowel disease patients.
2. What is evidence based medicine? Write about level of source of information for
best evidence.
3. Management of sleep disorder.
4. Discuss about the new anti-epileptic drugs.
5. Drug induced liver disorder.
6. A 26 year old man who presents with a prescription for sulfasalazine 500mg four
times a day. He has been referred to the gastroenterologist following a 3- month
history of abdominal pain, diarrhoea and several episodes of rectal bleeding. In-
patient investigation found mild ulcerative colitis extending through most of the
large bowel and most active proximally.
a) What monitoring should be carried out in patients starting sulfasalazine for
UC?
b) What information about the drug should be provided to the patient?
c) Why is sulfasalzine often of limited usefulness in Crohn?s disease?
?
*******?
FirstRanker.com - FirstRanker's Choice